Back to Search
Start Over
Phase I study of bortezomib plus ICE (BICE) for the treatment of relapsed/refractory Hodgkin lymphoma.
- Source :
- British Journal of Haematology; Jul2011, Vol. 154 Issue 2, p284-286, 3p, 1 Chart, 1 Graph
- Publication Year :
- 2011
-
Abstract
- The article offers information on Classical Hodgkin lymphoma (HL). It discusses the causes for the development of relapsed or refractory disease in the patients. The treatment for Hodgkin lymphoma through bortezomib plus ifosfamide, carboplatin, etoposide (BICE) has also been discussed in the article.
- Subjects :
- HODGKIN'S disease treatment
LYMPHOMAS
ANTINEOPLASTIC agents
ETOPOSIDE
PATHOLOGY
Subjects
Details
- Language :
- English
- ISSN :
- 00071048
- Volume :
- 154
- Issue :
- 2
- Database :
- Complementary Index
- Journal :
- British Journal of Haematology
- Publication Type :
- Academic Journal
- Accession number :
- 62013151
- Full Text :
- https://doi.org/10.1111/j.1365-2141.2011.08618.x